BioVigilant Systems
BioVigilant Systems develops rapid microbial monitoring technologies, including its foundational Instantaneous Microbial Detection platform, for pharmaceutical manufacturing and cleanroom environments. Founded in 2005 in Tucson, Arizona, with 11–50 employees, it operates as a private entity.
- Company typePrivate
- Founded2005
- HeadquartersTucson, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
BioVigilant Systems firmographics
Firmographics- Name
- BioVigilant Systems
- Website
- https://biovigilant.com
- Company type
- Private
- Founded year
- 2005
- Headcount range
- 11–50 employees
- Short description
- BioVigilant Systems develops rapid microbial monitoring technologies, including its foundational Instantaneous Microbial Detection platform, for pharmaceutical manufacturing and cleanroom environments. Founded in 2005 in Tucson, Arizona, with 11–50 employees, it operates as a private entity.
- Ownership category
- akta.pro rank
BioVigilant Systems industry classification
Industry- Product category
- Microbial Detection Instruments
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)
- akta.pro secondary industries
- Healthcare-Associated Infection (HAI) & Antimicrobial Resistance (AMR) Surveillance (HLAJABAH), Environmental Pathogen Monitoring Programs (Listeria, Salmonella, STEC) (AFALAEAA)
Keywords
Where BioVigilant Systems is headquartered
LocationHeadquarters
- HQ city
- Tucson
- HQ country
- United States
- HQ region
- North America
Markets served
BioVigilant Systems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
BioVigilant Systems product offering
Product offeringCore offering
BioVigilant Systems (operating as Azbil BioVigilant) develops technologies for rapid microbial monitoring methods (RMM) and is the inventor of Instantaneous Microbial Detection (IMD). The company provides instruments and detection systems that identify microorganisms in near real-time for pharmaceutical manufacturing, biotechnology, and other contamination-sensitive industrial environments.
Product overview
No product information available in the source data.
Differentiator
Problem solved
Functional benefit
Products and services
- Instantaneous Microbial Detection (IMD) Proprietary instrument-based detection system that identifies microorganisms in near real-time, replacing traditional culture-based microbial monitoring for pharmaceutical, biotech, and industrial customers.
- Rapid Microbial Monitoring (RMM) Technologies Rapid Microbial Monitoring methods and instruments designed for contamination detection and environmental monitoring in regulated industrial environments.
Companies that use BioVigilant Systems
Customer profileIdeal customer profiles1 record
BioVigilant Systems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BioVigilant Systems partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights2 records
BioVigilant Systems competitors and assessment
Company assessmentDirect peers
- Rapid Micro Biosystems: Specializes in automated, real-time microbial detection for pharmaceutical manufacturing cleanrooms — the closest direct competitor to BioVigilant's IMD technology and target use case.
- TSI Incorporated: Manufactures particle and microbial air samplers used in cleanroom environmental monitoring, with optical/biophotonic detection technology comparable to BioVigilant's IMD instruments.
Broad incumbents
- bioMérieux: Global leader in industrial and clinical microbiology, offering a broad portfolio of environmental monitoring instruments, reagents, and services that overlaps with BioVigilant's pharma RMM focus.
- Charles River Laboratories: Provides endotoxin and microbial detection products (e.g., Endosafe, Celsis) used in pharmaceutical quality control, competing directly with BioVigilant's rapid microbial detection offerings.
- Beckman Coulter (Danaher): Offers life-science instrumentation and microbiology testing platforms used in pharmaceutical QC and clinical labs, competing with BioVigilant across instrumentation, reagents, and service contracts.
- Bio-Rad Laboratories: Provides molecular and traditional microbiology instruments and consumables for pharma and food safety testing, including rapid detection systems that overlap with BioVigilant's offerings.
- MilliporeSigma (Merck KGaA Life Science): Supplies environmental monitoring consumables, instruments, and validation services for pharmaceutical manufacturing — competing with BioVigilant across the cleanroom monitoring value chain.
- BD (Becton, Dickinson and Company): Major diagnostics and life-sciences instruments manufacturer with microbiology and industrial testing capabilities that overlap BioVigilant's RMM and microbial detection market.
- Lonza Group: Provides microbial detection, endotoxin testing, and quality assurance solutions for pharmaceutical and biologics manufacturers, addressing the same customers as BioVigilant's cleanroom monitoring systems.
Emerging players
- Ecolab (Bioquell): Through its Bioquell business, Ecolab offers bio-decontamination and environmental monitoring solutions for life-science manufacturing, with adjacent technology that intersects BioVigilant's contamination control offerings.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights4 records
Customer concentration
BioVigilant Systems social profiles
Digital presenceBioVigilant Systems financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioVigilant Systems leadership team
Management profileNumber of profiles
Profiles1 record
BioVigilant Systems funding detail
Funding detailFunding overview
Funding rounds1 record
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioVigilant Systems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioVigilant Systems
What does BioVigilant Systems do?
BioVigilant Systems (operating as Azbil BioVigilant) develops technologies for rapid microbial monitoring methods (RMM) and is the inventor of Instantaneous Microbial Detection (IMD). The company provides instruments and detection systems that identify microorganisms in near real-time for pharmaceutical manufacturing, biotechnology, and other contamination-sensitive industrial environments.
Is BioVigilant Systems a public or private company?
BioVigilant Systems is a private company. It is classified as venture growth investor backed.
When was BioVigilant Systems founded?
BioVigilant Systems was founded in 2005. It employs 11 to 50 people.
Where is BioVigilant Systems based?
BioVigilant Systems is headquartered in Tucson, United States, in the North America region.
Who are BioVigilant Systems's main competitors?
Direct peers on record are Rapid Micro Biosystems and TSI Incorporated. Broad incumbents are bioMérieux, Charles River Laboratories, Beckman Coulter (Danaher), Bio-Rad Laboratories, MilliporeSigma (Merck KGaA Life Science), BD (Becton, Dickinson and Company) and Lonza Group. Ecolab (Bioquell) is listed as an emerging player.
Does BioVigilant Systems have an API?
No public API is recorded for BioVigilant Systems.
What industry is BioVigilant Systems in?
BioVigilant Systems's product category is Microbial Detection Instruments. Its primary akta.pro industry code is HLAAALAC, Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels), with a secondary code of HLAJABAH, Healthcare-Associated Infection (HAI) & Antimicrobial Resistance (AMR) Surveillance. Its NAICS code is 3345 and its SIC code is 2835.